DABUR logo
DABUR
Dabur India

Expansion Into E-commerce And Health Supplements Will Drive Future Growth

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 40 Analysts
Published
19 Nov 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
₹521.82
0.6% overvalued intrinsic discount
31 Jul
₹524.70
Loading
1Y
-16.6%
7D
1.2%

Author's Valuation

₹521.8

0.6% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Decreased 5.55%

Read more

Shared on23 Apr 25
Fair value Decreased 0.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 1.23%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Decreased 3.15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 0.029%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Decreased 0.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Decreased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Increased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more